{"id":52636,"date":"2023-01-06T15:02:59","date_gmt":"2023-01-06T14:02:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/"},"modified":"2023-01-06T15:02:59","modified_gmt":"2023-01-06T14:02:59","slug":"bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/","title":{"rendered":"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023"},"content":{"rendered":"
\n

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.\n<\/p>\n

<\/a><\/p>\n

\nTo participate, dial 844-200-6205 within the U.S. or +1 929-526-1599 outside the U.S., access code: 143970. A live webcast<\/a> of the conference call will also be available in the “Investor Relations” section of the company\u2019s website under “Events & Presentations” at investors.bio-rad.com<\/a>. A replay of the webcast will be available for up to a year.\n<\/p>\n

\nAbout Bio-Rad<\/b>\n<\/p>\n

\nBio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With 70 years of focus on quality and customer service, our products advance the scientific discovery process and improve healthcare. Our customers are universities, research institutions, hospitals, biotechnology and pharmaceutical companies, as well as public health and commercial laboratories including food safety and environmental quality testing facilities. Based in Hercules, California, Bio-Rad has a global network of operations with approximately 8,200 employees worldwide and $2.9 billion in revenues in 2021. For more information, please visit bio-rad.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Edward Chung, Investor Relations
\n
510-741-6104
\n
ir@bio-rad.com<\/a>\n<\/p>\n

\nMedia Contact:<\/b>
Anna Gralinska, Corporate Communications
\n
510-741-6643
\n
cc@bio-rad.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these results in a conference call scheduled for … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52636","6":"format-standard","7":"category-industry"},"yoast_head":"\nBio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these results in a conference call scheduled for ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-06T14:02:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230106005015\/en\/618489\/21\/Logo_RGB_on_transpar.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023\",\"datePublished\":\"2023-01-06T14:02:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/\"},\"wordCount\":265,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005015\\\/en\\\/618489\\\/21\\\/Logo_RGB_on_transpar.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/\",\"name\":\"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005015\\\/en\\\/618489\\\/21\\\/Logo_RGB_on_transpar.jpg\",\"datePublished\":\"2023-01-06T14:02:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005015\\\/en\\\/618489\\\/21\\\/Logo_RGB_on_transpar.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230106005015\\\/en\\\/618489\\\/21\\\/Logo_RGB_on_transpar.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/","og_locale":"en_US","og_type":"article","og_title":"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023 - Pharma Trend","og_description":"HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these results in a conference call scheduled for ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-06T14:02:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230106005015\/en\/618489\/21\/Logo_RGB_on_transpar.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023","datePublished":"2023-01-06T14:02:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/"},"wordCount":265,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230106005015\/en\/618489\/21\/Logo_RGB_on_transpar.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/","url":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/","name":"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230106005015\/en\/618489\/21\/Logo_RGB_on_transpar.jpg","datePublished":"2023-01-06T14:02:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230106005015\/en\/618489\/21\/Logo_RGB_on_transpar.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230106005015\/en\/618489\/21\/Logo_RGB_on_transpar.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bio-rad-to-report-fourth-quarter-and-full-year-2022-financial-results-on-thursday-february-16-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52636"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52636\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}